Literature DB >> 11822911

Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms.

M Yang1, M Butler.   

Abstract

Recombinant human erythropoietin (EPO) is a glycoprotein produced as a therapeutic agent from mammalian cell cultures for the treatment of anemia associated with severe kidney damage. The EPO structure has a high glycan content which is essential for bioactivity but shows considerable molecular heterogeneity. The cell culture conditions that affect the heterogeneity of the glycoforms of EPO are not well understood. However, the accumulation of ammonia in culture is one factor that has been associated with an enhanced heterogeneity of glycoforms. In this report we investigate the metabolic perturbations associated with ammonia and glucosamine that may give rise to an altered pattern of EPO glycosylation. Recombinant human erythropoietin was synthesized in serum-free cultures of transfected Chinese hamster ovary (CHO) cells. The molecular heterogeneity of erythropoietin was increased by supplementation of cultures with either ammonia or glucosamine. The enhanced molecular heterogeneity was shown to be due to variable glycosylation that resulted in EPO with an enhanced molecular weight and isoelectric point range. Enzymatic removal of the glycan moiety of EPO in all cases resulted in a single molecular form with a molecular weight of 18 000, which corresponded to non-glycosylated EPO. The variable glycosylation was consistent with reduced sialylation and antennarity of the carbohydrate structures present on the three N-linked sites of EPO. In the presence of ammonia (>30 mM) the proportion of tetrasialylated and tetraantennary glycan structures were reduced by 73% and 57%, respectively, as determined by HPLC analysis. Such changes were also observed, although to a lesser extent (41% and 37%), by an increase in the glucosamine concentration (>10 mM) in the medium. The enhanced heterogeneity of the glycan structures coincided with a significant increase in the intracellular UDP-N-acetylhexosamine (UDP-GNAc) pool. The measured UDP-GNAc level was up to 2 orders of magnitude higher in the presence of either glucosamine or ammonia. However, the changes in the glycosylation profiles induced by either glucosamine or ammonia were significantly different even at the same intracellular UDP-GNAc concentration. This suggests that the enhanced EPO heterogeneity could not be mediated solely by the increased UDP-GNAc level. Glucosamine (but not ammonia) was shown to cause significant inhibition of glucose transport into the cells, which could induce a different pattern of primary metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822911     DOI: 10.1021/bp0101334

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  21 in total

1.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

2.  Modifications of therapeutic proteins: challenges and prospects.

Authors:  Nigel Jenkins
Journal:  Cytotechnology       Date:  2007-05-25       Impact factor: 2.058

3.  Stability of Minimum Essential Medium functionality despite L-glutamine decomposition.

Authors:  Maja Jagušić; Dubravko Forčić; Marija Brgles; Leonida Kutle; Maja Šantak; Mladen Jergović; Ljerka Kotarski; Krešo Bendelja; Beata Halassy
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

4.  Glycosylation-related genes in NS0 cells are insensitive to moderately elevated ammonium concentrations.

Authors:  Arthur Nathan Brodsky; Mary Caldwell; Sooneon Bae; Sarah W Harcum
Journal:  J Biotechnol       Date:  2014-07-23       Impact factor: 3.307

5.  Glycosylation of Therapeutic Proteins: A Critical Quality Attribute.

Authors:  Arnaud Delobel
Journal:  Methods Mol Biol       Date:  2021

6.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

7.  Glycosylation and post-translational modification gene expression analysis by DNA microarrays for cultured mammalian cells.

Authors:  Arthur Nathan Brodsky; Mary Caldwell; Sarah W Harcum
Journal:  Methods       Date:  2011-10-19       Impact factor: 3.608

8.  High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Geun-Cheol Gil; Bryce Iliff; Ron Cerny; William H Velander; Kevin E Van Cott
Journal:  Anal Chem       Date:  2010-08-01       Impact factor: 6.986

9.  Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells.

Authors:  Thi Sam Nguyen; Ryo Misaki; Takao Ohashi; Kazuhito Fujiyama
Journal:  Cytotechnology       Date:  2020-03-03       Impact factor: 2.058

10.  Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.

Authors:  Deug-Nam Kwon; Hyuk Song; Jong-Yi Park; So-Young Lee; Seong-Keon Cho; Sung-Jo Kang; Joung Soon Jang; Han Geuk Seo; Jin-Hoi Kim
Journal:  Transgenic Res       Date:  2006-02       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.